Avandia: Lies, Damned Lies…and Statistics

Merck Recall Highlights Importance of Proper Filling

Surprising Number of U.S. Citizens Surveyed (by PhRMA) Import Drugs Without Prescription

FDA Needs to Get Out More:More Foreign API Plant Inspections Needed, But Where’s the Funding?

FDA’s Culture and Staff Retention: Another Locker Room Defection

Pharma and FDA: BIOCOM Survey Finds Communication, Agency Turnover are Key Problems

Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics

Wyeth’s Guayama Plant Gets Green Light from FDA; An Angry Mom Testifies Before the House on Antidepressant Safety

Can Pharma Learn From the Unfolding Gluten Contamination Story?

Ethics in Pharma: in Search of Tales from the Front